Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,300 peer-reviewed publications.

The CPRD bibliography is updated on a monthly basis (last updated 4 October 2019) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

(PDF, 3MB, 190 pages)

 

Export 2340 results:
Author Title [ Type(Desc)] Year
Journal Article
N. N. Mehta, Yu, Y., Pinnelas, R., Krishnamoorthy, P., Shin, D. B., Troxel, A. B., and Gelfand, J. M., “Attributable risk estimate of severe psoriasis on major cardiovascular events”, Am J Med, vol. 124, pp. 775.e1-6, 2011.
L. L. Lipscombe, Austin, P. C., Alessi-Severini, S., Blackburn, D. F., Blais, L., Bresee, L., Filion, K. B., Kawasumi, Y., Kurdyak, P., Platt, R. W., Tamim, H., and Paterson, J. M., “Atypical antipsychotics and hyperglycemic emergencies: multicentre, retrospective cohort study of administrative data”, Schizophr Res, vol. 154, pp. 54-60, 2014.
H. Jick and Kaye, J. A., “Autism and DPT vaccination in the United Kingdom”, N Engl J Med, vol. 350, pp. 2722-3, 2004.
A. Lawson, West, J., Aithal, G. P., and Logan, R. F., “Autoimmune cholestatic liver disease in people with coeliac disease: a population-based study of their association”, Aliment Pharmacol Ther, vol. 21, pp. 401-5, 2005.
K. W. Littink, Stappers, P. T. Y., Riemslag, F. C. C., Talsma, H. E., van Genderen, M. M., Cremers, F. P. M., Collin, R. W. J., and van den Born, L. I., “Autosomal Recessive NRL Mutations in Patients with Enhanced S-Cone Syndrome”, Genes (Basel), vol. 9, 2018.
I. J. Douglas, Bhaskaran, K., Batterham, R. L., and Smeeth, L., “Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care”, PLoS Med, vol. 12, p. e1001925, 2015.
K. van Brunt, Curtis, B., Ivanyi, T., Balogh, E., Chalkiadaki, C., MacLachlan, S., Neasham, D., and Raluy-Callado, M., “Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin”, Diabetes Ther, vol. 7, pp. 793-807, 2016.
S. F. Lanes, Rodrigeuz, L. A., and Hwangg, E., “Baseline risk of gastrointestinal disorders among new users of meloxicam, ibuprofen, diclofenac, naproxen and indomethacin”, Pharmacoepidemiol Drug Saf, vol. 9, pp. 113-7, 2000.
J. Stowe, Andrews, N., Wise, L., and Miller, E., “Bell's palsy and parenteral inactivated influenza vaccine”, Hum Vaccin, vol. 2, pp. 110-2, 2006.
J. P. Sheppard, Stevens, S., Stevens, R., Martin, U., Mant, J., Hobbs, F. D. R., and McManus, R. J., “Benefits and Harms of Antihypertensive Treatment in Low-Risk Patients With Mild Hypertension”, JAMA Intern Med, vol. 178, pp. 1626-1634, 2018.
D. B. Wolfson, Best, A. F., Addona, V., Wolfson, J., and Gadalla, S. M., “Benefits of combining prevalent and incident cohorts: An application to myotonic dystrophy”, Stat Methods Med Res, p. 962280218804275, 2018.
R. Alsaggaf, St George, D. M. M., Zhan, M., Pfeiffer, R. M., Wang, Y., Anderson, L. A., Liu, Z., Koshiol, J., Bauer, A. J., Wagner, K. R., Greene, M. H., Amr, S., and Gadalla, S. M., “Benign tumors in myotonic dystrophy type I target disease-related cancer sites”, Ann Clin Transl Neurol, vol. 6, pp. 1510-1518, 2019.
P. Imfeld, Bodmer, M., Jick, S. S., and Meier, C. R., “Benzodiazepine Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis”, Drug Saf, vol. 38, pp. 909-19, 2015.
A. Palmaro, Dupouy, J., and Lapeyre-Mestre, M., “Benzodiazepines and risk of death: Results from two large cohort studies in France and UK”, Eur Neuropsychopharmacol, vol. 25, pp. 1566-77, 2015.
C. McCourt, Coleman, H. G., Murray, L. J., Cantwell, M. M., Dolan, O., Powe, D. G., and Cardwell, C. R., “Beta-blocker usage after malignant melanoma diagnosis and survival: a population-based nested case-control study”, Br J Dermatol, vol. 170, pp. 930-8, 2014.
C. R. Cardwell, Coleman, H. G., Murray, L. J., Entschladen, F., and Powe, D. G., “Beta-blocker usage and breast cancer survival: a nested case-control study within a UK clinical practice research datalink cohort”, Int J Epidemiol, vol. 42, pp. 1852-61, 2013.
B. M. Hicks, Murray, L. J., Powe, D. G., Hughes, C. M., and Cardwell, C. R., “beta-Blocker usage and colorectal cancer mortality: a nested case-control study in the UK Clinical Practice Research Datalink cohort”, Ann Oncol, vol. 24, pp. 3100-6, 2013.
C. Renoux, Dell'Aniello, S., Brenner, B., and Suissa, S., “Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 554-560, 2017.
S. J. Sinnott, Mansfield, K. E., Schmidt, M., Bhaskaran, K., Smeeth, L., Nitsch, D., and Tomlinson, L. A., “Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin-angiotensin system blockers: a UK primary care cohort study”, BMJ Open, vol. 7, p. e018153, 2017.
J. Spoendlin, Meier, C., Jick, S. S., and Meier, C. R., “Bisphosphonate therapy start may transiently increase the risk of tendon rupture in patients with glucocorticoid co-medication: a population-based observational study”, Pharmacoepidemiol Drug Saf, vol. 25, pp. 1116-1123, 2016.
W. G. Dixon and Solomon, D. H., “Bisphosphonates and esophageal cancer–a pathway through the confusion”, Nat Rev Rheumatol, vol. 7, pp. 369-72, 2011.
E. Wright, Schofield, P. T., Seed, P., and Molokhia, M., “Bisphosphonates and risk of upper gastrointestinal cancer–a case control study using the General Practice Research Database (GPRD)”, PLoS One, vol. 7, p. e47616, 2012.
C. Ang, Doyle, E., and Branch, A., “Bisphosphonates as potential adjuvants for patients with cancers of the digestive system”, World J Gastroenterol, vol. 22, pp. 906-16, 2016.
K. Donegan, Beau-Lejdstrom, R., King, B., Seabroke, S., Thomson, A., and Bryan, P., “Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK”, Vaccine, vol. 31, pp. 4961-7, 2013.
O. A. Oshagbemi, Franssen, F. M. E., van Kraaij, S., Braeken, D. C. W., Wouters, E. F. M., van der Zee, A. H. Maitlan, Driessen, J. H. M., and de Vries, F., “Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD)”, Copd, pp. 1-8, 2019.
O. A. Oshagbemi, Franssen, F. M. E., Braeken, D. C. W., Henskens, Y., Wouters, E. F. M., van der Zee, A. H. Maitlan, Burden, A. M., and de Vries, F., “Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality”, Pharmacoepidemiol Drug Saf, vol. 27, pp. 1191-1199, 2018.
C. A. Emdin, Rothwell, P. M., Salimi-Khorshidi, G., Kiran, A., Conrad, N., Callender, T., Mehta, Z., Pendlebury, S. T., Anderson, S. G., Mohseni, H., Woodward, M., and Rahimi, K., “Blood Pressure and Risk of Vascular Dementia: Evidence From a Primary Care Registry and a Cohort Study of Transient Ischemic Attack and Stroke”, Stroke, vol. 47, pp. 1429-35, 2016.
J. Delgado, Bowman, K., Ble, A., Masoli, J., Han, Y., Henley, W., Welsh, S., Kuchel, G. A., Ferrucci, L., and Melzer, D., “Blood Pressure Trajectories in the 20 Years Before Death”, JAMA Intern Med, vol. 178, pp. 93-99, 2018.
N. Qizilbash, Gregson, J., Johnson, M. E., Pearce, N., Douglas, I., Wing, K., Evans, S. J. W., and Pocock, S. J., “BMI and risk of dementia in two million people over two decades: a retrospective cohort study”, Lancet Diabetes Endocrinol, vol. 3, pp. 431-436, 2015.
H. Strongman, Brown, A., Smeeth, L., and Bhaskaran, K., “Body mass index and Hodgkin's lymphoma: UK population-based cohort study of 5.8 million individuals”, Br J Cancer, 2019.
W. A. Blumentals, Nevitt, A., Peng, M. M., and Toovey, S., “Body mass index and the incidence of influenza-associated pneumonia in a UK primary care cohort”, Influenza Other Respir Viruses, vol. 6, pp. 28-36, 2012.
S. Kent, Jebb, S. A., Gray, A., Green, J., Reeves, G., Beral, V., Mihaylova, B., and Cairns, B. J., “Body mass index and use and costs of primary care services among women aged 55-79 years in England: a cohort and linked data study”, Int J Obes (Lond), 2018.
K. Bhaskaran, Douglas, I., Forbes, H., dos-Santos-Silva, I., Leon, D. A., and Smeeth, L., “Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults”, Lancet, vol. 384, pp. 755-65, 2014.
W. G. Herrington, Smith, M., Bankhead, C., Matsushita, K., Stevens, S., Holt, T., Hobbs, F. D., Coresh, J., and Woodward, M., “Body-mass index and risk of advanced chronic kidney disease: Prospective analyses from a primary care cohort of 1.4 million adults in England”, PLoS One, vol. 12, p. e0173515, 2017.
J. H. Driessen, Henry, R. M., van Onzenoort, H. A., Lalmohamed, A., Burden, A. M., Prieto-Alhambra, D., Neef, C., Leufkens, H. G., and de Vries, F., “Bone fracture risk is not associated with the use of glucagon-like peptide-1 receptor agonists: a population-based cohort analysis”, Calcif Tissue Int, vol. 97, pp. 104-12, 2015.
R. I. Furlano, Bloechliger, M., Jick, H., and Meier, C. R., “Bone fractures in children with autistic spectrum disorder”, J Dev Behav Pediatr, vol. 35, pp. 353-9, 2014.
A. Gonzalez-Perez, Ronquist, G., and Rodriguez, L. A. Garcia, “Breast cancer incidence and use of antihypertensive medication in women”, Pharmacoepidemiol Drug Saf, vol. 13, pp. 581-5, 2004.
A. Gonzalez-Perez and Rodriguez, L. A. Garcia, “Breast cancer risk among users of antidepressant medications”, Epidemiology, vol. 16, pp. 101-5, 2005.
V. Abbing-Karahagopian, Kurz, X., de Vries, F., van Staa, T. P., Alvarez, Y., Hesse, U., Hasford, J., Dijk, L., de Abajo, F. J., Weil, J. G., Grimaldi-Bensouda, L., Egberts, A. C., Reynolds, R. F., and Klungel, O. H., “Bridging differences in outcomes of pharmacoepidemiological studies: design and first results of the PROTECT project”, Curr Clin Pharmacol, vol. 9, pp. 130-8, 2014.
V. Navaratnam, Millett, E. R., Hurst, J. R., Thomas, S. L., Smeeth, L., Hubbard, R. B., Brown, J., and Quint, J. K., “Bronchiectasis and the risk of cardiovascular disease: a population-based study”, Thorax, vol. 72, pp. 161-166, 2017.
S. Langham, Wright, A., Shaw, H., Bryson, S., and O'Leary, S., “Budget impact analysis of oral glycopyrronium bromide (Sialanar™) for the symptomatic treatment of severe sialorrhoea (Drooling) in the UK setting”, Value in Health, vol. 20, p. A720, 2017.
F. Rees, Doherty, M., Grainge, M., Lanyon, P., Davenport, G., and Zhang, W., “Burden of Comorbidity in Systemic Lupus Erythematosus in the UK, 1999-2012”, Arthritis Care Res (Hoboken), vol. 68, pp. 819-27, 2016.
E. A. Yanni, Ferreira, G., Guennec, M., Y. Hahi, E., A. Ghachi, E., Haguinet, F., Espie, E., and Bianco, V., “Burden of herpes zoster in 16 selected immunocompromised populations in England: a cohort study in the Clinical Practice Research Datalink 2000-2012”, BMJ Open, vol. 8, p. e020528, 2018.
R. D. Pockett, Watkins, J., McEwan, P., and Meier, G., “Burden of Illness in UK Subjects with Reported Respiratory Infections Vaccinated or Unvaccinated against Influenza: A Retrospective Observational Study”, PLoS One, vol. 10, p. e0134928, 2015.
L. Grimaldi-Bensouda, Klungel, O., Kurz, X., de Groot, M. C., Afonso, A. S. Maciel, De Bruin, M. L., Reynolds, R., and Rossignol, M., “Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD)”, BMJ Open, vol. 6, p. e009147, 2016.
H. Jick, “Calcium-channel blockers and risk of cancer”, Lancet, vol. 349, pp. 1699-700, 1997.
C. Canavan, West, J., and Card, T., “Calculating Total Health Service Utilisation and Costs from Routinely Collected Electronic Health Records Using the Example of Patients with Irritable Bowel Syndrome Before and After Their First Gastroenterology Appointment”, Pharmacoeconomics, vol. 34, pp. 181-94, 2016.
D. A. Springate, Ashcroft, D. M., Kontopantelis, E., Doran, T., Ryan, R., and Reeves, D., “Can analyses of electronic patient records be independently and externally validated? Study 2–the effect of beta-adrenoceptor blocker therapy on cancer survival: a retrospective cohort study”, BMJ Open, vol. 5, p. e007299, 2015.
D. Reeves, Springate, D. A., Ashcroft, D. M., Ryan, R., Doran, T., Morris, R., Olier, I., and Kontopantelis, E., “Can analyses of electronic patient records be independently and externally validated? The effect of statins on the mortality of patients with ischaemic heart disease: a cohort study with nested case-control analysis”, BMJ Open, vol. 4, p. e004952, 2014.
S. H. Landis, Wurst, K., Le, H. V., Bonar, K., and Punekar, Y. S., “Can Assessment of Disease Burden Prior to Changes in Initial COPD Maintenance Treatment Provide Insight into Remaining Unmet Needs? A Retrospective Database Study in UK Primary Care”, Copd, vol. 14, pp. 80-85, 2017.
[Page last reviewed 4 October 2019]